ICD-10-CM Code C94.21
Acute megakaryoblastic leukemia, in remission
BILLABLE
|
ICD-10 from 2011 - 2016
Billable Code
Billable codes are sufficient justification for admission to an acute care hospital when used a principal diagnosis.C94.21 is a billable ICD code used to specify a diagnosis of acute megakaryoblastic leukemia, in remission. A 'billable code' is detailed enough to be used to specify a medical diagnosis.
The ICD code C942 is used to code Acute megakaryoblastic leukemia
Acute megakaryoblastic leukemia (AMKL) is a form of leukemia where a majority of the blasts are megakaryoblastic.
Specialty: | Hematology And Oncology |
MeSH Code: | D007947 |
AML-M7, bone marrow section
MS-DRG Mapping
- DRG Group #820-822 - Lymphoma and leukemia with major operating room procedure with MCC.
- DRG Group #820-822 - Lymphoma and leukemia with major operating room procedure with CC.
- DRG Group #820-822 - Lymphoma and leukemia with major operating room procedure without CC or MCC.
- DRG Group #823-825 - Lymphoma and non-acute leukemia with other operating room procedure with MCC.
- DRG Group #823-825 - Lymphoma and non-acute leukemia with other operating room procedure with CC.
- DRG Group #823-825 - Lymphoma and non-acute leukemia with other operating room procedure without CC or MCC.
- DRG Group #840-842 - Lymphoma and non-acute leukemia with MCC.
- DRG Group #840-842 - Lymphoma and non-acute leukemia with CC.
- DRG Group #840-842 - Lymphoma and non-acute leukemia without CC or MCC.
Equivalent ICD-9 Code GENERAL EQUIVALENCE MAPPINGS (GEM)
Megakaryocytic leukemia, in remission
(approximate match)
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code C94.21 and a single ICD9 code, 207.21 is an approximate match for comparison and conversion purposes.
Parent Code: C94.2 - Acute megakaryoblastic leukemia